Northwestern University Feinberg School of Medicine

Lurie Cancer Center Professional Education Events

3rd Annual Lurie Cancer Center OncoSET Symposium: The Future Is Now

On Friday, April 26, 2019 the OncoSET Symposium will provide healthcare professionals with state-of-the-art information related to significant advances in precision medicine for cancer and the evolving standard of personalized cancer care. The program will focus on emerging technologies used to generate large scale genomic data and the steps to filter, evaluate and apply this knowledge to determine the most effective course of treatment for each patient. Symposium participants will discover new approaches to personalized cancer therapy based on current research and patient-specific genetic patterns. Participants will examine technological advances, such as artificial intelligence, challenges in genomic sequencing and molecular analysis, and germline genotype and pharmacogenetics. In addition, participants will develop strategies for translating advances in precision medicine into the clinical setting.

2019 Presentation Access

Event Details

Friday, April 26, 2019

Registration & Breakfast: 8:00 a.m.
Program: 9:00 a.m. - 5:00 p.m.

Northwestern Memorial Hospital, Feinberg Pavilion

251 E. Huron St., Chicago
3rd Floor Conference Center

Agenda (PDF) Register

Keynote Speaker

Timothy Yap
Timothy Yap, MD, PhD

Associate Professor, Investigational Cancer Therapeutics
Associate Director of Translational Research
Khalifa Institute for Personalized Cancer Therapy
Medical Director, Institute for Applied Cancer Science
MD Anderson Cancer Center

Confirmed Faculty

Aditya Bardia, MBBS, MPH, Massachusetts General Hospital

Amir Behdad, MD, Lurie Cancer Center

Massimo Cristofanilli, MD, Lurie Cancer Center

Juan José Díaz-Mochón, PhD, GENYO, Centro Pfizer-Universidad de Granada, Spain

Charles Drake, MD, PhD, Herbert Irving Comprehensive Cancer Center

William Gradishar, MD, Lurie Cancer Center

Stanley Hamilton, MD, MD Anderson Cancer Center

Raghu Kalluri, MD, PhD, MD Anderson Cancer Center

Jose Lorente, MD, PhD, GENYO, Centro Pfizer-Universidad de Granada, Spain

Devalingam Mahalingam, MD, PhD, Lurie Cancer Center

Leonidas Platanias, MD, PhD, Lurie Cancer Center

Luis Raez, MD, Memorial Healthcare System

Isidore Rigoutsos, PhD, Thomas Jefferson University

Christian Rolfo, MD, PhD, MBA, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center

Carolien Schröder, MD, PhD, University of Groningen, Netherlands

María José Serrano, PhD, GENYO, Centro Pfizer-Universidad de Granada, Spain

Jeffrey Sosman, MD, Lurie Cancer Center

Conference Fees

Lurie Cancer Center Affiliate Rates
Affiliates include Northwestern University, Northwestern Medicine, Northwestern Medical Group, Lurie Children's, Rehabilitation Institute of Chicago and Jesse Brown VA
  Student, Fellow or Resident Complimentary
  Nurse or Allied Health Professional $25
  Research Staff $25
  Faculty and/or Physician $50
General Rates
  Student, Fellow or Resident Complimentary
  Nurse or Allied Health Professional $50
  Research Staff $50
  Faculty and/or Physician $75
  Industry Representative $250

Onsite registration will be available, but we encourage all participants to register in advance.

Conference Chairs

Leonidas C. Platanias, MD, PhD
Lurie Cancer Center

Massimo Cristofanilli, MD
Lurie Cancer Center

Accreditation Information

Target Audience

This activity is intended for healthcare professionals involved in the treatment and care of patients with advanced or refractory cancers for whom precision medicine can help guide treatment choices. This includes medical, surgical, and radiation oncologists, pathologists, radiologists, other translational-oriented laboratory scientists, nurses, pharmacists, genetic counselors, and physician assistants.


  1. Define and discuss the use of clinical genomics and its use in the personalization of treatment for patients with both solid tumors and hematologic malignancies.
  2. Identify emerging approaches to acquiring and analyzing genomic information.
  3. Describe, discuss, and illustrate the roles of genomic sequencing, molecular analysis with standard pathology, precisely targeted treatments and clinical trials, and the benefits they confer on patients.
  4. Define both the challenges and the opportunities faced in the implementation of genomic sequencing in the treatment of cancer patients.
  5. Cite the current status of evaluation of liquid biopsies in clinical management of solid tumors.
  6. Identify emerging blood-based molecular diagnostics for longitudinal monitoring of cancer patients.

Accreditation Statement

The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

The Northwestern University Feinberg School of Medicine designates this live activity for a maximum of 7 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Credits

The American Academy of Nurse Practitioners and the American Nurses Credentialing Center accept AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.

Faculty Disclosure

Current guidelines state that participants in CME activities should be made aware of any affiliation of financial interest that may affect the speaker's presentation. Each speaker has been requested to complete a faculty disclosure form. The names of faculty members declaring a relationship or who will be discussing off-label usage will be indicated in the course syllabus.

Additional Information

The 3rd Annual OncoSET Symposium: The Future is Now is being conducted in collaboration with the International Society of Liquid Biopsy (ISLB).

For additional information about the event, please contact Erin Donoghue, Manager of Professional Education, at or 312-695-1392.

See also the OncoSET Precision Medicine webpage.

Back to top